Cary J Nolan insider trades: TomoTherapy (TOMO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cary reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 12, 2010 | TOMO | ↓ Sell | 15,000 | $3.70 | $56K | Direct | May 12, 2010 (0d) |
| Apr 29, 2010 | TOMO | ↓ Sell | 15,000 | $3.90 | $59K | Direct | Apr 30, 2010 (1d) |
| Mar 10, 2010 | TOMO | ↓ Sell | 31,000 | $3.22 | $100K | Direct | Mar 11, 2010 (1d) |
| Feb 25, 2010 | TOMO | ↓ Sell | 25,000 | $3.39 | $85K | Direct | Feb 26, 2010 (1d) |
| Oct 16, 2007 | TTPY | ↓ Sell | 84,719 | $22.25 | $1.9M | Direct | Oct 18, 2007 (2d) |
| May 14, 2007 | TTPY | ↓ Sell | 13,600 | $19.00 | $258K | Direct | Aug 20, 2007 (98d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Cary J Nolan's insider trades
Cary J Nolan is a director at TomoTherapy (TOMO). Since May 14, 2007, Cary has reported no open-market purchases and 6 sales worth $2.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TOMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.